HTA4 A Comprehensive Review of Health Technology Reassessments for Oncology Drugs in Fran Impact on Reimbursement Outcomes 2019-2024
Abstract
Authors
Mark Chalmers PRATEEK KANADE Love Kumar Vidhyasagari Sundaram Darata Zemaitaityte